Skip to main content

Cormorant Asset Management, LP

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1583977 BOSTON, MA

Position in AXSM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,451,000
-$5,247,000 QoQ
Shares Held
50,000
-33.3% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in AXSM

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,451,000 50,000
2025-12-31 $13,698,000 75,000
2025-09-30 $12,145,000 100,000
2025-06-30 $10,439,000 100,000
2025-03-31 $29,157,500 250,000
2024-12-31 $27,498,250 325,000
2024-09-30 $35,948,000 400,000
2024-06-30 $32,200,000 400,000
2023-06-30 $24,432,400 340,000
2023-03-31 $18,504,000 300,000
2022-12-31 $25,067,250 325,000
2022-06-30 $7,851,500 205,000
2021-03-31 $11,324,000 200,000
2020-12-31 $16,294,000 200,000
2020-09-30 $17,812,500 250,000
2020-06-30 $28,798,000 350,000
2020-03-31 $29,415,000 500,000